Get the Stockscreener App
1.69
1.17%
-0.02
After Hours:
1.72
0.03
+1.78%
Bluejay Diagnostics Inc stock is traded at $1.69, with a volume of 117.81K.
It is down -1.17% in the last 24 hours and down -59.67% over the past month.
Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.
See More
Previous Close:
$1.71
Open:
$1.74
24h Volume:
117.81K
Relative Volume:
0.11
Market Cap:
$2.88M
Revenue:
-
Net Income/Loss:
$-8.59M
P/E Ratio:
-0.00123
EPS:
-1373
Net Cash Flow:
$-9.25M
1W Performance:
-27.47%
1M Performance:
-59.67%
6M Performance:
-69.30%
1Y Performance:
-99.32%
1-Day Range:
$1.65
$1.77
1-Week Range:
$1.60
$2.32
52-Week Range:
$1.60
$316.92
Bluejay Diagnostics Inc Stock (BJDX) Company Profile
Name
Bluejay Diagnostics Inc
Sector
Industry
Phone
(978) 631-0152
Address
360 MASSACHUSETTS AVENUE, SUITE 203, ACTON
Compare BJDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BJDX
Bluejay Diagnostics Inc
|
1.69 | 2.88M | 0 | -8.59M | -9.25M | -1,373.00 |
|
ABT
Abbott Laboratories
|
131.73 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.05 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
348.12 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.37 | 106.90B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.60 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Bluejay Diagnostics Inc Stock (BJDX) Latest News
BJDX stock touches 52-week low at $2.22 amid sharp annual decline By Investing.com - Investing.com South Africa
BJDX stock touches 52-week low at $2.22 amid sharp annual decline - Investing.com India
Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting - The Manila Times
Breakthrough Sepsis Test Could Predict Patient Mortality Risk, New Study Reveals - Stock Titan
Bluejay Diagnostics Secures $3.7 Million Through Warrant Inducement Transaction - citybuzz -
Small Cap Stocks To Watch NowApril 7th - MarketBeat
Bluejay Diagnostics slumps after raising $3.7M through warrant exercise deal - MSN
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.84% - Investing.com
United States shares lower at close of trade; Dow Jones Industrial Average down 0.84% - Investing.com India
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.84% - Investing.com UK
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
BJDX stock touches 52-week low at $3.01 amid steep annual decline By Investing.com - Investing.com South Africa
BJDX stock touches 52-week low at $3.01 amid steep annual decline - Investing.com
Dow Jumps Over 1,100 Points; US Small Business Sentiment Falls In March - Benzinga
US Markets Rebound As Global Trade Tensions Persist - Finimize
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Jack Kellogg Called The Market Bottom - timothysykes.com
Bluejay Diagnostics Plunges Premarket After Investors Agree to Exercise Warrants at Reduced Price - MarketScreener
Bluejay Diagnostics Sinks Premarket Following Investor Agreement to Exercise Warrants at 'Reduced' Price - MarketScreener
Bluejay Diagnostics enters into agreement with institutional investors - Medical Buyer
Why Levi Strauss Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga
Bluejay Diagnostics Raises $3.7M Through Warrant Deal, Stock Slides After-Hours While Retail Interest Surges - NewsBreak: Local News & Alerts
Bluejay Diagnostics (BJDX) Secures $3.7M Through Warrant Exercis - GuruFocus
Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds - The Manila Times
Bluejay Diagnostics Announces Entry Into Warrant Inducement Transaction For Approximately $3.7 Million In Gross Proceeds - marketscreener.com
Bluejay Diagnostics Raises Fresh $3.7M Capital: New Warrant Deal Strengthens Balance Sheet - Stock Titan
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Vermilion Energy Inc. Confirms First Quarter 2025 Release Date and Filing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders - Yahoo Finance
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Nasdaq Surges Over 400 Points; China Pharma Shares Plummet - Benzinga
ADDING MULTIMEDIA Altus Capital Partners Together With Centerfield Capital and ALM Management Acquire ALM Positioners, Inc. - Yahoo Finance
Ardonagh Advisory acquires ALP Holdings and its subsidiary - Yahoo Finance
Diagnostic Green Announces the Return of IC-Green® to the Market and Corporate Support for Groundbreaking Cancer Trial - Yahoo Finance
Bluejay Diagnostics: A Roller Coaster Week - timothysykes.com
IBM Acquires Hakkoda Inc., Expanding Data Expertise to Fuel Clients' AI Transformations - Yahoo Finance
Berkshire Hathaway (BRK-B) And Vltava Fund’s Investment Approach - Yahoo Finance
Is United Rentals (URI) Trading at Attractive Price? - Yahoo Finance
Stramsen Biotech Inc. Announced $25 Million Funding Commitment from GEM Global Yield LLC SCS ("GEM") - Yahoo Finance
Is It Too Late To Consider Buying Performance Food Group Company (NYSE:PFGC)? - Yahoo Finance
Oil drops to four-year low, metals fall on recession fears - Yahoo Finance
Is Enlivex Therapeutics (NASDAQ:ENLV) In A Good Position To Invest In Growth? - Yahoo Finance
Cintas Corporation (CTAS) Dropped -11% in Q4 - Yahoo Finance
Hub Group, Inc.'s (NASDAQ:HUBG) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong? - Yahoo Finance
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Is Adobe Inc. (ADBE) the Best High-Risk Stock to Buy According to Billionaires? - Yahoo Finance
Myriad Genetics Names Brian Donnelly as New Chief Commercial Officer - Yahoo Finance
Earnings grew faster than the favorable 19% CAGR delivered to Park-Ohio Holdings (NASDAQ:PKOH) shareholders over the last three years - Yahoo Finance
Emerging Stocks Sink Most Since 2008 as Tariff Turmoil Deepens - Yahoo Finance
Why Chanson International Holding Shares Are Trading Higher By Around 170%; Here Are 20 Stocks Moving Premarket - Benzinga
Apyx Medical (NASDAQ:APYX) & Bluejay Diagnostics (NASDAQ:BJDX) Head-To-Head Review - Defense World
At US$15.27, Is Monro, Inc. (NASDAQ:MNRO) Worth Looking At Closely? - Yahoo Finance
Bluejay Diagnostics Inc Stock (BJDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):